drugset / Trial / NCT00461305
Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to investigate efficacy of ethinylestradiol for intracyclic bleeding profile in patients with dysmenorrhea and to investigate the long term safety
Timeline
- Start
- 2007-02
- Primary completion
- 2009-01
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | drospirenone | Unknown | 3 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 20 ug | Oral |
| Subject | ethinyl estradiol | Small molecule | 30 ug | Oral |